Mark A. Arredondo
About
In The Last Decade
Mark A. Arredondo
19 papers receiving 974 citations
Peers
Comparison fields: 5 of 71
- Oncology 379
- Pathology and Forensic Medicine 377
- Cancer Research 362
- Radiology, Nuclear Medicine and Imaging 351
- Pulmonary and Respiratory Medicine 186
Countries citing papers authored by Mark A. Arredondo
This map shows the geographic impact of Mark A. Arredondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Arredondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Arredondo more than expected).
Fields of papers citing papers by Mark A. Arredondo
This network shows the impact of papers produced by Mark A. Arredondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Arredondo. The network helps show where Mark A. Arredondo may publish in the future.
Co-authorship network of co-authors of Mark A. Arredondo
This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Arredondo. A scholar is included among the top collaborators of Mark A. Arredondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Arredondo. Mark A. Arredondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Gold nanoparticle uptake is enhanced by estradiol in MCF-7 breast cancer cells | 2 |
| 2 | Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. | 20 |
| 3 | 219 | |
| 4 | Sarcoma of the breast: implications of the extent of local therapy. | 27 |
| 5 | 103 | |
| 6 | 4 | |
| 7 | 30 | |
| 8 | 208 | |
| 9 | 11 | |
| 10 | DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. | 51 |
| 11 | 184 | |
| 12 | New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. | 45 |
| 13 | 6 | |
| 14 | 3 | |
| 15 | Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor. | 31 |
| 16 | Comparison of an immunoperoxidase "sandwich" staining method and western blot detection of P-glycoprotein in human cell lines and sarcomas. | 16 |
| 17 | 29 | |
| 18 | 9 | |
| 19 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.